These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 5023769)

  • 1. Potency and coagulation factor effects of 2,3,5,6-tetrachloro-4-pyridinol compared to warfarin and its antagonism by vitamin K.
    Marshall FN
    Proc Soc Exp Biol Med; 1972 Mar; 139(3):806-10. PubMed ID: 5023769
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of nitro-- derivatives of warfarin on blood coagulation].
    Lakin KM; Smirnova TV; Karaseva MG; Fel'dbaum VA
    Farmakol Toksikol; 1967; 30(4):456-60. PubMed ID: 5598901
    [No Abstract]   [Full Text] [Related]  

  • 3. Warfarin and the inhibition of vitamin K activity by an oxide metabolite.
    Bell RG; Matschiner JT
    Nature; 1972 May; 237(5349):32-3. PubMed ID: 4555434
    [No Abstract]   [Full Text] [Related]  

  • 4. Warfarin therapy. 1.
    Deykin D
    N Engl J Med; 1970 Sep; 283(13):691-4. PubMed ID: 4916914
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of warfarin, phenylindanedione, tetrachloropyridinol, and chloro-vitamin K1 on prothrombin synthesis and vitamin K metabolism in normal and warfarin-resistant rats.
    Ren P; Laliberte RE; Bell RG
    Mol Pharmacol; 1974 May; 10(3):373-80. PubMed ID: 4851787
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental warfarin poisoning in the dog. Platelet function, coagulation and fibrinolysis.
    Forbes CD; Thomson C; Prentice CR; McNicol GP; McEwan AD
    J Comp Pathol; 1973 Apr; 83(2):173-80. PubMed ID: 4761660
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of daphnin on blood coagulation].
    Lakin KM; Kosheleva LI
    Farmakol Toksikol; 1968; 31(1):72-4. PubMed ID: 5675354
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1953 Sep; 31(33-34):781-7. PubMed ID: 13097910
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence for a humoral agent capable of raising vitamin-K-dependent coagulation factors in rabbits.
    Karpatkin M; Karpatkin S
    Br J Haematol; 1973 May; 24(5):553-62. PubMed ID: 4712828
    [No Abstract]   [Full Text] [Related]  

  • 10. Coagulation and fibrinolysis in normal women immediately post partum and in newborn infants. Influence of prophylactic vitamin K.
    Nielsen NC
    Acta Obstet Gynecol Scand; 1969; 48(3):371-91. PubMed ID: 5370777
    [No Abstract]   [Full Text] [Related]  

  • 11. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].
    FORELL MM; KOLLER F
    Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anticoagulant of indirect action nitropharin].
    Lakin KM; Smirnova TV; Karaseva MG
    Farmakol Toksikol; 1968; 31(2):184-7. PubMed ID: 5674673
    [No Abstract]   [Full Text] [Related]  

  • 13. The anticoagulant activity of 3-1-phenyl-propyl-4-hydroxycoumarin in patients on "long-term" therapy.
    Bourgain RH; Vanden Driessche R; Smets P
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):240-6. PubMed ID: 5015934
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the mode of action of vitamin K.
    Olson RE
    Adv Enzyme Regul; 1966; 4():181-96. PubMed ID: 4168681
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypersensitivity to warfarin in rats with Walker 256 carcinoma.
    Owen CA
    Proc Soc Exp Biol Med; 1982 Jan; 169(1):1-3. PubMed ID: 7063488
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemostatic toxicity of Poly I-C.
    Gralnick HR; Shott LL; Zendzian RP; Homan E
    Toxicol Appl Pharmacol; 1972 May; 22(1):146-9. PubMed ID: 5034982
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of warfarin and edoxaban, an oral direct factor Xa inhibitor, on gammacarboxylated (Gla-osteocalcin) and undercarboxylated osteocalcin (uc-osteocalcin) in rats.
    Morishima Y; Kamisato C; Honda Y; Furugohri T; Shibano T
    Thromb Res; 2013 Jan; 131(1):59-63. PubMed ID: 22999414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin K deficiency, warfarin, and inhibitors of protein synthesis upon the plasma levels of vitamin K-dependent clotting factors in the chick.
    Walz DA; Kipfer RK; Olson RE
    J Nutr; 1975 Aug; 105(8):972-81. PubMed ID: 1142015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin K and warfarin. Metabolism, function and interaction.
    Woolf IL; Babior BM
    Am J Med; 1972 Sep; 53(3):261-7. PubMed ID: 5054720
    [No Abstract]   [Full Text] [Related]  

  • 20. Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony.
    Scott EA; Sandler GA; Byars TD
    Am J Vet Res; 1978 Dec; 39(12):1888-91. PubMed ID: 749570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.